Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation

New England Journal of Medicine

Volumn 345, Issue 4, 2001, Pages 235-240

  Modan, Baruch ^a   Hartge, Patricia ^b   Hirsh Yechezkel, Galit ^a   Chetrit, Angela ^a   Lubin, Flora ^a   Beller, Uzi ^c   Ben Baruch, Gilad ^a   Fishman, Amiram ^d   Menczer, Joseph ^e   Struewing, Jeffery P ^b   Tucker, Margaret A ^b   Wacholder, Sholom ^b   Ebbers, Sara M ^b   Friedman, Eitan ^a   Piura, Benjamin ^f  

^a SHEBA MEDICAL CENTER   (Israel)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

^d MEIR MEDICAL CENTER   (Israel)

^e WOLFSON MEDICAL CENTER   (Israel)

^f BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; ORAL CONTRACEPTIVE AGENT;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; ISRAEL; JEW; MAJOR CLINICAL STUDY; MULTIPARA; OVARY CANCER; PRIORITY JOURNAL;

ADULT; AGED; BRCA2 PROTEIN; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; GENES, BRCA1; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; JEWS; LOGISTIC MODELS; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PARITY; RISK; TRANSCRIPTION FACTORS;

EID: 0035954651     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200107263450401     Document Type: Article

References (29)

1. Measuring the separate effects of low parity and its antecedents on the incidence of ovarian cancer
2. Parity, age at first childbirth, and risk of ovarian cancer
3. Ovarian cancer, ovulation and side of origin
4. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico
5. Cancer incidence in a cohort of infertile women
6. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer
7. A case-control study of epithelial ovarian cancer
8. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use
9. Determinants of ovarian cancer risk. I. Reproductive experiences and family history
10. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women
11. Risk factors for ovarian cancer: A case-control study
12. Hormonal aspects of epithelial ovarian cancer: Review of epidemiological evidence
13. Risk factors in ovarian cancer
14. Risk factors for familial and sporadic ovarian cancer among French Canadians: A case-control study
15. Reproductive, genetic, and dietary risk factors for ovarian cancer
16. High frequency of BRCA1 185delAG mutation in ovarian cancer in Israel: National Israel Study of Ovarian Cancer
17. Founder BRCA1/2 mutations among male patients with breast cancer in Israel
18. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies
19. Incidence of ovarian cancer in relation to the use of oral contraceptives
20. Oral contraceptive use and the risk of ovarian cancer: An Italian case-control study
21. Limitations of the case-only design for identifying gene-environment interaction
22. Oral contraceptives and the risk of hereditary ovarian cancer
23. Incessant ovulation - A factor in ovarian neoplasia?
24. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis
25. Effect of progestin on the ovarian epithelium of macaques: Cancer prevention through apoptosis?
26. The impact of progestin potency in oral contraceptives on the risk of ovarian cancer
27. Does oral contraceptive use increase the risk of breast cancer in women with BRCA1/BRCA2 mutations more than in other women?
28. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer
29. BRCA1, BRCA2 mutation and pedigree analysis to determine genetic risk in the UK Royal Marsden Hospital Tamoxifen Prevention trial